National Institute for Clinical Excellence (NICE). Heavy menstrual bleeding March 2018, www.nice.org.uk/guidance/cg88 (accessed 7 December 2018).
2.
ACOG Committee OpinionNo. 556. Postmenopausal oestrogen therapy: route of administration and risk of venous thromboembolism. Obstet Gynaecol2013;
121: 887–890.
3.
SmithNLBlondonMWigginsKLet al.
Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens.JAMA2014;
174: 25–31.
4.
CanonicoMOgerEPlu-bureauGet al.; Estrogen and Thromboembolism Risk (ESTHER) Study Group.
Hormone therapy and venous thromboembolism among post menopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.Circulation2007;
115: 840–845.
5.
IdleSAPanayNHamodaH.A national survey assessing the clinical practice of members of the British Menopause Society on the management of patients with unscheduled bleeding on hormone replacement therapy. Post Reproductive Health2018;
24: 128.
